Arrowhead Research | ARWR - Market Capitalization


Arrowhead Research reported $8.98B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Arrowhead Research USD 4.77B 2.59B Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Ligand Pharmaceuticals USD 3.42B 1.23B Sep/2025
Merck USD 293.38B 83.74B Feb/2026
Moderna USD 10.09B 581M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
TG Therapeutics USD 5.74B 21M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025
Xencor USD 837M 278M Sep/2025